#162: Beta blockers of no use in stable CAD; docs debate valve choice; Montreal cardiologist suspended; adherence to warfarin-adjustment algorithm sharpens anticoagulation: RE-LY; CV risk prediction: CRP, fibrinogen add modestly
Beta blockers of no use in stable CAD; docs debate valve choice; Montreal cardiologist suspended; adherence to warfarin-adjustment algorithm sharpens anticoagulation: RE-LY; CV risk prediction: CRP, fibrinogen add modestly (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 12, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#16: LVAD therapy for patients with congestive heart failure
Guest host Dr Margaret Redfield discusses the basics of left ventricular assist devices (LVADs)—as bridge to transplant, destination therapy, and bridge to recovery—with leading heart-failure surgeon Dr Soon Park. What role are LVADs playing in HF? (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 10, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
#161: Single-drug polypharmacy; dabigatran use climbing in US; consistent benefit of apixaban: ARISTOTLE; sulfonylurea cardiotoxicity probed; Bonhoeffer to be struck off medical register
Single-drug polypharmacy; dabigatran use climbing in US; consistent benefit of apixaban: ARISTOTLE; sulfonylurea cardiotoxicity probed; Bonhoeffer to be struck off medical register (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 5, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#160: Statins and diabetes risk: More data; clopidogrel poststenting: The case for shorter duration, interruptions; EMA supports apixaban for AF/stroke; statins do not reduce the risk of VTE: New meta-analysis; rethinking routine testing of chest-pain pat
Statins and diabetes risk: More data; clopidogrel poststenting: The case for shorter duration, interruptions; EMA supports apixaban for AF/stroke; statins do not reduce the risk of VTE: New meta-analysis; rethinking routine testing of chest-pain patients (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - September 28, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#15: Healthcare reform--All doom and gloom?
In the context of shrinking funds and an aging population (10 000 people turn 65 each day), what is the status of healthcare reform in the US? Guest host Dr Chet Rihal catches up with Dr Ray Gibbons for a frank discussion on where things stand, what ... (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - September 28, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
#159: Renal denervation cost-effective for resistant hypertension; no CV benefit of omega-3 fatty acids: Meta-analysis; doing nothing about CVD will cost $47 trillion; decline in nuclear tests per patient; restless legs linked to CHD
Renal denervation cost-effective for resistant hypertension; no CV benefit of omega-3 fatty acids: Meta-analysis; doing nothing about CVD will cost $47 trillion; decline in nuclear tests per patient; restless legs linked to CHD (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - September 21, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#158: NSAID risk persists five years post-MI; Obesity paradox strengthened by new SCAAR data in ACS; RELY finds dabigatran bleeding-related gene variant; Antihypertensive use in pregnancy up; Door-to-activation times drives PCI delays
Published each Friday, this podcast delivers the week's five most popular articles in audio format. Stay on top of the latest cardiology news, wherever your week takes you. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - September 14, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#51: Stem-cell therapy in cardiovascular medicine: An update with Dr Bobby Robbins
Regenerative therapy using stem cells has—for a long time—shown great potential to impact cardiovascular medicine. What's the current state of the field? (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - September 10, 2012 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#157: Chocolate reduces stroke risk in men; RE-LY Registry: Wide global variation in AF management, mortality; apixaban for AF patients with renal dysfunction?; CDC: US losing war against hypertension; ATLAS ACS 2 TIMI 51: 2.5-mg rivaroxaban cuts cardiac
Chocolate reduces stroke risk in men; RE-LY Registry: Wide global variation in AF management, mortality; apixaban for AF patients with renal dysfunction?; CDC: US losing war against hypertension; ATLAS ACS 2 TIMI 51: 2.5-mg rivaroxaban cuts cardiac events (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - September 7, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#14: Sudden cardiac death in the young: The role of arrhythmogenic right ventricular dysplasia
Sudden cardiac death in the young: The role of arrhythmogenic right ventricular dysplasia (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - September 7, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
#156: Results from ESC 2012; TRILOGY ACS: No win for prasugrel; WOEST: Drop aspirin in stent patients on oral anticoagulants; ALTITUDE: New data on why trial halted; PARAMOUNT phase 2; IABP SHOCK II; New European STEMI guidelines; HPS2-THRIVE
Results from ESC 2012; TRILOGY ACS: No win for prasugrel; WOEST: Drop aspirin in stent patients on oral anticoagulants; ALTITUDE: New data on why trial halted; PARAMOUNT phase 2: Agent shows promise in preserved-EF HF; IABP SHOCK II: No survival benefit o (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - August 31, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#13: Hemodynamic subsets in aortic stenosis: It's not so simple
Mayo Clinic cardiovascular fellow Dr Mackram Eleid joins Dr Bernard Gersh to discuss his research on the complicated subject of low flow, low gradient aortic stenosis, and particularly why it's important to examine the disease as systemic, involving the a (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - August 26, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
#155: ESC 2012: What's going to be hot; MIST investigator charges Circulation, AHA, with "breaking their own rules" on disclosure; FDA: Get X-rays of Riata lead; Meta-analysis challenges drug use in mild hypertension; PINNACLE-AF: slow uptake of new antic
ESC 2012: What's going to be hot; MIST investigator charges Circulation, AHA, with "breaking their own rules" on disclosure; FDA: Get X-rays of Riata lead; Meta-analysis challenges drug use in mild hypertension; PINNACLE-AF: slow uptake of new antic (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - August 24, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#154: JUPITER analysis on diabetes risk with statins; statins linked to cataracts; chocolate nudges down BP in meta-analysis; bleeding risk tools compared in AF; troponin algorithm rules MI in or out in 77% of chest-pain patients
JUPITER analysis on diabetes risk with statins; statins linked to cataracts; chocolate nudges down BP in meta-analysis; bleeding risk tools compared in AF; troponin algorithm rules MI in or out in 77% of chest-pain patients (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - August 17, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#153: AHA/ASA advisory on stroke prevention in AF; possible dabigatran, rivaroxaban antidotes; lip-cancer risk raised by photosensitizing antihypertensives; paper disputes MI count in TRITON, RECORD, and PLATO; US government investigates HCA hospitals
AHA/ASA advisory on stroke prevention in AF; possible dabigatran, rivaroxaban antidotes work in vitro in human blood; lip-cancer risk raised by photosensitizing antihypertensives; paper disputes MI count in TRITON, RECORD, and PLATO; US government i (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - August 10, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
